Previous close | 79.20 |
Open | 79.20 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 260.00 |
Expiry date | 2025-01-17 |
Day's range | 79.20 - 79.20 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...